GlassScriptPhysician profile
Kenneth Cartledge
NPI 1124063052
$1,640.81
in general payments reported to CMS, 2019-2025
21 companies · $537 in 2025
The $537 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $153 · 2023: $415 · 2024: $326 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $304.31 | 2021-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $258.28 | 2021-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $181.91 | 2021-2025 | Entyvio, Gattex |
| Braintree Laboratories, INC. | $124.98 | 2023-2024 | Sutab, Suflave |
| Ardelyx, INC. | $104.46 | 2022-2025 | Ibsrela |
| Ferring Pharmaceuticals INC. | $98.43 | 2023 | Rebyota, Cimzia, Clenpiq |
| Becton, Dickinson and Company | $90.69 | 2025 | Hemosphere |
| Regeneron Healthcare Solutions, INC. | $84.00 | 2022-2024 | Dupixent |
| Nestle Healthcare Nutrition INC. | $57.19 | 2022-2023 | |
| Lilly USA, LLC | $42.28 | 2024-2025 | Omvoh |
| Medtronic, INC. | $41.76 | 2021 | |
| Fisher & Paykel Healthcare INC | $39.89 | 2024-2025 | Fisher & Paykel Healthcare |
| Qol Medical, LLC | $32.60 | 2021 | |
| Abiomed | $32.23 | 2024 | |
| Madrigal Pharmaceuticals | $31.89 | 2024 | Resmetirom |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $24.85 | 2025 | Teg6s Hemostasis System |
| Abbvie INC. | $24.73 | 2021 | |
| Intercept Pharmaceuticals, INC. | $17.07 | 2022 | |
| Olympus America INC. | $17.03 | 2025 | Evis Exera III Colonovideoscope |
| Merck Sharp & Dohme LLC | $16.74 | 2025 | Bridion |
| Redhill Biopharma INC. | $15.49 | 2024 | Talicia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Cartledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.